Sunday, November 24, 2024
11/24/2024
The proposed Project ARTEMIS (AHN Researching Treatment Effectiveness and Medical Integration through SBIRT) will implement evidence-based SBIRT practices via an integrated care model at two (2) primary care sites, in Allegheny County, Pennsylvania, to increase the early identification of adult patients who are at risk for or have substance use disorders (SUDs) and facilitate their access to appropriate SUD (including medication assisted treatment (MAT)) and other behavioral health treatment services. Project ARTEMIS is a collaboration between a vertically integrated health system, Allegheny Health Network (AHN), and its Medicaid and commercial managed care organizations, Gateway Health Plan and Highmark Health Plan. AHN is in the process of building and implementing a primary care redesign strategy wherein integrated, team-based healthcare delivery models will be rolled out at 17 primary care sites throughout Western Pennsylvania by the end of 2018. An integral part of the primary care redesign initiative will be the integration of SUD and behavioral health treatment services within a new clinically integrated network (CIN). The population of focus includes patients 18 years and older within Allegheny County who may present with risky substance use or behavioral health needs at (1) Green Tree Medical Associates and (2) Wexford Health and Wellness Pavilion. This population is mostly white, English speaking, and has less than 10% of patients living below the poverty level. It is estimated that over the course of the project 25,000 patients will be served. Project ARTEMIS aims to (1) integrate SBIRT and behavioral health activities within two sites using an evidence-based framework; (2) implement an integrated, team-based care model, including evidence-based care coordination activities; (3) ensure all data is collected and reported accurately through the implementation of robust data collection and continuous quality improvement (CQI) processes; (4) evaluate the patient outcomes, cost-effectiveness, and cost-benefits of the project to demonstrate the return on investment for the cost of SBIRT implementation; (5) utilize robust CQI processes to ensure SBIRT services are carried out with fidelity and address disparities in the target population; and (6) develop a sustainable funding mechanism so healthcare providers can bill and receive reimbursement. The University of Pittsburgh School of Pharmacy, Program Evaluation and Research Unit (PERU) and RTI International are also collaborators on Project Artemis and will serve as its primary evaluators. These teams will assist with GPRA data collection and conduct quality improvement evaluations with project site staff to assess for barriers and find solutions. RTI International will collect cost and utilization data to evaluate the cost-effectiveness and cost-benefit of the provided SBIRT services.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
